SNSS : Summary for Sunesis Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets open in 2 hrs 34 mins

Sunesis Pharmaceuticals, Inc. (SNSS)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.87-0.01 (-0.26%)
At close: 4:00PM EST
People also watch
CYCCTHLDRPRXAEZSSNTA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close3.88
Open3.85
Bid0.00 x
Ask0.00 x
Day's Range3.71 - 4.00
52 Week Range2.64 - 6.30
Volume57,713
Avg. Volume57,909
Market Cap80.8M
Beta1.11
PE Ratio (TTM)-1.32
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • How MEI Pharma Inc (MEIP) Stacks Up Against Its Peers
    Insider Monkeylast month

    How MEI Pharma Inc (MEIP) Stacks Up Against Its Peers

    It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity. As a result, most investors pick their illusory “winners” by making a superficial analysis and research that leads to poor performance on aggregate. The Standard and Poor’s 500 Index returned 7.6% over […]

  • GlobeNewswire2 months ago

    Sunesis Pharmaceuticals Announces Presentations at ASH Annual Meeting

    SOUTH SAN FRANCISCO, Calif., Nov. 03, 2016-- Sunesis Pharmaceuticals, Inc. today announced an oral and a poster presentation at the 58th American Society of Hematology Annual Meeting to be held December ...

  • GlobeNewswire2 months ago

    Sunesis Pharmaceuticals Reports Third Quarter 2016 Financial Results and Recent Highlights

    SOUTH SAN FRANCISCO, Calif., Nov. 03, 2016-- Sunesis Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2016. Loss from operations for the three months ended ...